Oseltamivir Prescription and Regulatory Actions Vis-à-Vis Abnormal Behavior Risk in Japan: Drug Utilization Study Using a Nationwide Pharmacy Database

BACKGROUND: In March 2007, a regulatory advisory was issued in Japan to restrict oseltamivir use in children aged 10-19 years because of safety concerns over abnormal behavior. The effectiveness and validity of regulatory risk minimization actions remain to be reviewed, despite their significant pub...

Descripción completa

Detalles Bibliográficos
Autores principales: Urushihara, Hisashi, Doi, Yuko, Arai, Masaru, Matsunaga, Toshiyuki, Fujii, Yosuke, Iino, Naoko, Kawamura, Takashi, Kawakami, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232227/
https://www.ncbi.nlm.nih.gov/pubmed/22163021
http://dx.doi.org/10.1371/journal.pone.0028483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232227/
https://www.ncbi.nlm.nih.gov/pubmed/22163021
http://dx.doi.org/10.1371/journal.pone.0028483

Ejemplares similares